An affinity-matured DLL4 ligand for broad-spectrum activation and inhibition of Notch signaling
Gonzalez-Perez, D.; Das, S.; Medina, E.; Antfolk, D.; Egan, E. D.; Blacklow, S. C.; Rodriguez, P. C.; Luca, V. C.
Show abstract
The Notch pathway regulates cell fate decisions and is an emerging target for regenerative and cancer therapies. Recombinant Notch ligands are attractive candidates for modulating Notch signaling; however, their intrinsically low receptor-binding affinity restricts their utility in biomedical applications. To overcome this limitation, we evolved variants of the ligand Delta-like 4 (DLL4) with enhanced affinity and cross-reactivity. A consensus variant with maximized binding affinity, DeltaMAX, engages human and murine Notch receptors with 500- to 1000-fold increased affinity compared to wild-type human DLL4. DeltaMAX also potently activates human Notch in plate-bound, bead-bound, and cellular formats. When administered as a soluble decoy, DeltaMAX inhibits Notch activation in response to either Delta-like (DLL) or Jagged (Jag) ligands, highlighting its utility as both an agonist and antagonist. Finally, we demonstrate that DeltaMAX stimulates increased proliferation and expression of effector mediators in primary activated human T cells. Taken together, our data defines DeltaMAX as a versatile biotechnological tool for broad-spectrum activation or inhibition of Notch signaling.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Intestinal Paneth cell differentiation relies on asymmetric regulation of Wnt signaling by Daam1/2 95%
- Modulating immune cell fate and inflammation through CRISPR-mediated DNA methylation editing 95%
- Mechanistic Insights into the Stimulation of the Histone H3K9 Methyltransferase Clr4 by Proximal H3K14 Ubiquitination 95%
Similar papers in this journal
- Molecular Features Underlying Shp1/Shp2 Discrimination by Immune Checkpoint Receptors 96%
- Harnessing Notch signaling to decode mechanisms of proteolytic regulation in diverse cell-surface receptors 96%
- Discovery of a molecular glue promoting CDK12-DDB1 interaction to trigger Cyclin K degradation 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.